• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5.内在分子动力学如何控制转录因子STAT5信号转导与激活因子中的分子内通讯。
PLoS One. 2015 Dec 30;10(12):e0145142. doi: 10.1371/journal.pone.0145142. eCollection 2015.
2
Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.粒细胞集落刺激因子在髓系细胞中激活的Stat5亚型的描绘与定位
Blood Cells Mol Dis. 2000 Aug;26(4):320-30. doi: 10.1006/bcmd.2000.0309.
3
Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.生长激素激活的信号转导子及转录激活子5a(STAT5a)和STAT5b的丝氨酸磷酸化:对STAT5转录活性的影响
Mol Endocrinol. 2001 Dec;15(12):2157-71. doi: 10.1210/mend.15.12.0746.
4
Differential function of STAT5 isoforms in head and neck cancer growth control.信号转导和转录激活因子5(STAT5)亚型在头颈部癌生长控制中的差异功能
Oncogene. 2002 Apr 25;21(18):2846-53. doi: 10.1038/sj.onc.1205385.
5
Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.催乳素(PRL)与雄激素对人乳腺癌细胞中PRL诱导蛋白基因表达的协同作用:一种转录信号转导子与激活子5和雄激素受体之间功能协同作用的独特模型。
Mol Endocrinol. 2002 Jul;16(7):1696-710. doi: 10.1210/mend.16.7.0875.
6
Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.SHP-2 酪氨酸磷酸酶的显性负性变体可抑制 Jak2(Janus 激酶 2)的催乳素激活以及 Stat5(信号转导子和转录激活子 5)依赖性转录的诱导。
Mol Endocrinol. 1998 Apr;12(4):556-67. doi: 10.1210/mend.12.4.0086.
7
Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.白细胞介素-2家族细胞因子刺激人类T细胞中Stat5转录因子的Pro-Ser-Pro基序磷酸化:对多种丝氨酸激酶途径抑制的抗性
J Leukoc Biol. 2002 Oct;72(4):819-28.
8
Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.催乳素信号在小鼠下丘脑主要由信号转导子和转录激活因子 5b 介导,而不是 5a。
J Neuroendocrinol. 2012 Dec;24(12):1484-91. doi: 10.1111/j.1365-2826.2012.02357.x.
9
Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.Src直接在其激活位点对STAT5进行酪氨酸磷酸化,并参与促红细胞生成素诱导的信号通路。
Oncogene. 2001 Oct 4;20(45):6643-50. doi: 10.1038/sj.onc.1204807.
10
Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.信号转导及转录激活因子5的激活足以驱动细胞周期蛋白D2基因的转录诱导及大鼠胰腺β细胞的增殖。
Mol Endocrinol. 2003 May;17(5):945-58. doi: 10.1210/me.2002-0356. Epub 2003 Feb 13.

引用本文的文献

1
The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain.致癌驱动突变N642H对STAT5B SH2结构域的结构影响。
Protein Sci. 2025 Jan;34(1):e70022. doi: 10.1002/pro.70022.
2
Evolutionary, comparative, and functional analyses of STATs and regulation of the JAK-STAT pathway in lumpfish upon bacterial and poly(I:C) exposure.鱼类 STAT 基因的进化、比较和功能分析及其在细菌和 Poly(I:C)刺激下 JAK-STAT 通路的调控
Front Cell Infect Microbiol. 2023 Sep 22;13:1252744. doi: 10.3389/fcimb.2023.1252744. eCollection 2023.
3
Allosteric regulation in STAT3 interdomains is mediated by a rigid core: SH2 domain regulation by CCD in D170A variant.变构调节在 STAT3 结构域间通过刚性核心介导:SH2 结构域通过 D170A 变体中的 CCD 调节。
PLoS Comput Biol. 2022 Dec 21;18(12):e1010794. doi: 10.1371/journal.pcbi.1010794. eCollection 2022 Dec.
4
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.信号转导和转录激活因子3(STAT3)及信号转导和转录激活因子5(STAT5)的Src同源2(SH2)结构域突变的结构影响
Cancers (Basel). 2019 Nov 8;11(11):1757. doi: 10.3390/cancers11111757.
5
Structural and functional consequences of the STAT5B driver mutation.STAT5B 驱动突变的结构和功能后果。
Nat Commun. 2019 Jun 7;10(1):2517. doi: 10.1038/s41467-019-10422-7.

本文引用的文献

1
An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".与磷酸化肽结合的STAT5的SH2结构域模型定义了“STAT5结合特征”。
J Comput Aided Mol Des. 2015 May;29(5):451-70. doi: 10.1007/s10822-015-9835-6. Epub 2015 Mar 10.
2
Nanomolar inhibitors of the transcription factor STAT5b with high selectivity over STAT5a.对转录因子STAT5b具有纳摩尔级抑制作用且对STAT5a具有高选择性的抑制剂。
Angew Chem Int Ed Engl. 2015 Apr 13;54(16):4758-63. doi: 10.1002/anie.201410672. Epub 2015 Feb 20.
3
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein.STAT5蛋白的纳摩尔效价小分子抑制剂。
ACS Med Chem Lett. 2014 Sep 19;5(11):1202-1206. doi: 10.1021/ml500165r. eCollection 2014 Nov 13.
4
Allosteric pathway identification through network analysis: from molecular dynamics simulations to interactive 2D and 3D graphs.通过网络分析进行变构途径识别:从分子动力学模拟到交互式二维和三维图形
Faraday Discuss. 2014;169:303-21. doi: 10.1039/c4fd00024b. Epub 2014 May 30.
5
Hotspot mutations in KIT receptor differentially modulate its allosterically coupled conformational dynamics: impact on activation and drug sensitivity.KIT 受体热点突变差异调节其变构偶联构象动力学:对激活和药物敏感性的影响。
PLoS Comput Biol. 2014 Jul 31;10(7):e1003749. doi: 10.1371/journal.pcbi.1003749. eCollection 2014 Jul.
6
The natural chemopreventive agent sulforaphane inhibits STAT5 activity.天然化学预防剂萝卜硫素可抑制信号转导子和转录激活子5(STAT5)的活性。
PLoS One. 2014 Jun 9;9(6):e99391. doi: 10.1371/journal.pone.0099391. eCollection 2014.
7
Differential effects of CSF-1R D802V and KIT D816V homologous mutations on receptor tertiary structure and allosteric communication.集落刺激因子1受体(CSF-1R)D802V和原癌基因c-KIT D816V同源突变对受体三级结构和变构通讯的差异影响
PLoS One. 2014 May 14;9(5):e97519. doi: 10.1371/journal.pone.0097519. eCollection 2014.
8
Molecular defects in mastocytosis: KIT and beyond KIT.肥大细胞增多症中的分子缺陷:KIT 及 KIT 以外的因素。
Immunol Allergy Clin North Am. 2014 May;34(2):239-62. doi: 10.1016/j.iac.2014.01.009.
9
Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.慢性粒细胞白血病和肥大细胞增多症中协同作用的STAT5和AKT信号通路:可能的新治疗靶点。
Haematologica. 2014 Mar;99(3):417-29. doi: 10.3324/haematol.2013.098442.
10
The synthetic α-bromo-2',3,4,4'-tetramethoxychalcone (α-Br-TMC) inhibits the JAK/STAT signaling pathway.合成的α-溴-2',3,4,4'-四甲氧基查耳酮(α-Br-TMC)抑制JAK/STAT信号通路。
PLoS One. 2014 Mar 3;9(3):e90275. doi: 10.1371/journal.pone.0090275. eCollection 2014.

内在分子动力学如何控制转录因子STAT5信号转导与激活因子中的分子内通讯。

How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5.

作者信息

Langenfeld Florent, Guarracino Yann, Arock Michel, Trouvé Alain, Tchertanov Luba

机构信息

Laboratoire de Biologie et Pharmacologie Appliquée Ecole Normale Supérieure de Cachan, CNRS, Université Paris-Saclay, Cachan, France.

Centre de Mathématiques et de Leurs applications, Ecole Normale Supérieure de Cachan, CNRS, Université Paris-Saclay, Cachan, France.

出版信息

PLoS One. 2015 Dec 30;10(12):e0145142. doi: 10.1371/journal.pone.0145142. eCollection 2015.

DOI:10.1371/journal.pone.0145142
PMID:26717567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4696835/
Abstract

Signal Transducer and Activator of Transcription STAT5 is a key mediator of cell proliferation, differentiation and survival. While STAT5 activity is tightly regulated in normal cells, its constitutive activation directly contributes to oncogenesis and is associated with a broad range of hematological and solid tumor cancers. Therefore the development of compounds able to modulate pathogenic activation of this protein is a very challenging endeavor. A crucial step of drug design is the understanding of the protein conformational features and the definition of putative binding site(s) for such modulators. Currently, there is no structural data available for human STAT5 and our study is the first footprint towards the description of structure and dynamics of this protein. We investigated structural and dynamical features of the two STAT5 isoforms, STAT5a and STAT5b, taken into account their phosphorylation status. The study was based on the exploration of molecular dynamics simulations by different analytical methods. Despite the overall folding similarity of STAT5 proteins, the MD conformations display specific structural and dynamical features for each protein, indicating first, sequence-encoded structural properties and second, phosphorylation-induced effects which contribute to local and long-distance structural rearrangements interpreted as allosteric event. Further examination of the dynamical coupling between distant sites provides evidence for alternative profiles of the communication pathways inside and between the STAT5 domains. These results add a new insight to the understanding of the crucial role of intrinsic molecular dynamics in mediating intramolecular signaling in STAT5. Two pockets, localized in close proximity to the phosphotyrosine-binding site and adjacent to the channel for communication pathways across STAT5, may constitute valid targets to develop inhibitors able to modulate the function-related communication properties of this signaling protein.

摘要

信号转导子和转录激活子STAT5是细胞增殖、分化和存活的关键调节因子。虽然STAT5的活性在正常细胞中受到严格调控,但其组成型激活直接促进肿瘤发生,并与多种血液系统和实体肿瘤相关。因此,开发能够调节该蛋白致病性激活的化合物是一项极具挑战性的工作。药物设计的关键步骤是了解蛋白质的构象特征以及此类调节剂假定结合位点的定义。目前,尚无人类STAT5的结构数据,我们的研究是描述该蛋白结构和动力学的第一步。我们研究了两种STAT5亚型STAT5a和STAT5b的结构和动力学特征,并考虑了它们的磷酸化状态。该研究基于通过不同分析方法对分子动力学模拟的探索。尽管STAT5蛋白的整体折叠相似,但分子动力学构象对每种蛋白都显示出特定的结构和动力学特征,这首先表明了序列编码的结构特性,其次表明了磷酸化诱导的效应,这些效应导致局部和长距离的结构重排,被解释为变构事件。对远距离位点之间动态耦合的进一步研究为STAT5结构域内部和之间通信途径的替代模式提供了证据。这些结果为理解内在分子动力学在介导STAT5分子内信号传导中的关键作用提供了新的见解。两个口袋位于靠近磷酸酪氨酸结合位点且与贯穿STAT5的通信途径通道相邻的位置,可能构成开发能够调节这种信号蛋白功能相关通信特性的抑制剂的有效靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/5e558fb8b79a/pone.0145142.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/b9c6f4773bb7/pone.0145142.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/aa3ad6af8bb2/pone.0145142.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/7a758a867e1d/pone.0145142.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/50b2b67114f2/pone.0145142.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/e746a5d35fdc/pone.0145142.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/d25c7b262c43/pone.0145142.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/8c28fde83c05/pone.0145142.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/92b7fc02c5c5/pone.0145142.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/9d854a056c66/pone.0145142.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/5e558fb8b79a/pone.0145142.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/b9c6f4773bb7/pone.0145142.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/aa3ad6af8bb2/pone.0145142.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/7a758a867e1d/pone.0145142.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/50b2b67114f2/pone.0145142.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/e746a5d35fdc/pone.0145142.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/d25c7b262c43/pone.0145142.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/8c28fde83c05/pone.0145142.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/92b7fc02c5c5/pone.0145142.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/9d854a056c66/pone.0145142.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/4696835/5e558fb8b79a/pone.0145142.g010.jpg